Evolus EOLS
NASDAQ EOLS
$8.40 -0.20 (-2.33%)
At close: Aug 20, 2026 · 1:55 PM UTC

Evolus (EOLS) EPS (Diluted) (2020 - 2026)

Evolus (EOLS) EPS (Diluted) (2020 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Haleon 43.91 Bn 42.95 Bn - -
2 Teva Pharmaceutical Industries 42.98 Bn 39.32 Bn 2.15 Bn -0.49
3 Zoetis 31.53 Bn 29.86 Bn 1.05 Bn 2.07
4 Takeda Pharmaceutical 28.61 Bn 22.81 Bn 5.10 Bn 0.45
5 United Therapeutics 22.16 Bn 19.49 Bn 683.80 Mn 7.27
6 Viatris 18.74 Bn 17.85 Bn 1.46 Bn -0.10
7 Neurocrine Biosciences 15.51 Bn 15.12 Bn 935.80 Mn 1.39
8 Elanco Animal Health 11.76 Bn 11.23 Bn 798.00 Mn 0.11
9 Dr Reddys Laboratories 10.12 Bn 9.95 Bn - -
10 Evolus 554.79 Mn 509.62 Mn 57.18 Mn -0.12

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.12
Mar 31, 2026 -0.16
Dec 31, 2025 0.00
Sep 30, 2025 -0.24
Jun 30, 2025 -0.27
Mar 31, 2025 -0.30
Dec 31, 2024 -0.11
Sep 30, 2024 -0.30
Jun 30, 2024 -0.18
Mar 31, 2024 -0.22
Dec 31, 2023 -0.21
Sep 30, 2023 -0.30
Jun 30, 2023 -0.32
Mar 31, 2023 -0.26
Dec 31, 2022 -0.23
Sep 30, 2022 -0.36
Jun 30, 2022 -0.42
Mar 31, 2022 -0.31
Dec 31, 2021 -0.37
Sep 30, 2021 -0.35